1.Hypoxia-inducible factor-1α and CD133 predicts pathological complete response and survival for locally advanced rectal cancer patients after neoadjuvant chemoradiotherapy.
Cheng CAI ; Jianping WANG ; Zhifeng ZHONG ; Zhihui DAI ; Qinghua WANG ; Wuzhen DONG ; Hongqi SHI ; Qingwei LIU ; Jinlin DU
Journal of Zhejiang University. Medical sciences 2017;46(1):36-43
To investigate the expression of hypoxia-inducible factor 1α (HIF-1α) and CD133 in predicting pathologic remission and survival of patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.One hundred and fourteen patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy from January 2010 to December 2015 in Jinhua Municipal Central Hospital were enrolled in the study. RT-PCR and immunohistochemistry methods were used to detect the mRNA and protein expression of HIF-1α and CD133 before and after chemoradiotherapy. Spearman rank correlation was used to analyze the correlation between HIF-1α and CD133 mRNA expression. Univariate and logistic multivariate analyses were used to determine the factors related to pathological complete response (pCR). Logistic regression analysis and Cox's proportional hazard model were used to determine factors related to overall survival and recurrence-free survival.The expression of HIF-1α and CD133 mRNA was correlated with pT, ypTNM, pCR, recurrence and metastasis of rectal cancer, while not correlated with sex, age and BMI of patients. HIF-1α mRNA expression was positively correlated with CD133 mRNA expression (=0.579,=0.000). Immunohistochemistry analysis showed that residual cancer cells strongly expressing HIF-1α also expressed CD133 strongly. Univariate analysis showed that HIF-1α mRNA and CD133 mRNA were significantly correlated with pCR (=0.001,=0.022, respectively). Multivariate analysis showed that HIF-1α and CD133 mRNA expression were independent prognostic factors of pCR (=0.012,=0.047, respectively). Cox regression analysis showed that the expression of HIF-1α mRNA and CD133 mRNA were independent predictors of recurrence-free survival and overall survival (=0.025,=0.033, respectively).The study indicates that HIF-1α and CD133 can predict pathological complete remission and survival of patients with locally advanced rectal cancer.
AC133 Antigen
;
analysis
;
genetics
;
Biomarkers, Tumor
;
analysis
;
Chemoradiotherapy
;
Disease-Free Survival
;
Female
;
Humans
;
Hypoxia-Inducible Factor 1, alpha Subunit
;
analysis
;
genetics
;
Male
;
Neoadjuvant Therapy
;
Neoplasm Grading
;
Neoplasm Metastasis
;
diagnosis
;
Neoplasm Recurrence, Local
;
epidemiology
;
genetics
;
Neoplasm, Residual
;
genetics
;
Prognosis
;
Proportional Hazards Models
;
Rectal Neoplasms
;
chemistry
;
epidemiology
;
genetics
;
therapy
;
Survival Rate
2.Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms.
Luohai CHEN ; Minhu CHEN ; Jie CHEN
Chinese Journal of Gastrointestinal Surgery 2017;20(3):357-360
Gastroenteropancreatic neuroendocrine neoplam (GEP-NEN) is a rare group of tumors with its incidence rising significantly in recent decades. Because of the late presentation of the disease and limitations in conventional biomarkers, about 50% of GEP-NEN patients manifests advanced disease when diagnosed. Therefore, it is vital to identify circulating biomarkers which can not only be used for early diagnosis but also accurately evaluating the biological behavior of GEP-NEN. This review summarizes the advances of circulating biomarkers in diagnosing and evaluating efficacy of treatment in GEP-NEN. Well-known circulating biomarkers include chromogranin A (CgA), pancreastatin (PST), chromogranin B (CgB), neuron-specific enolase (NSE) and pancreatic peptide(PP). Novel biomarkers including circulating tumor cell(CTC), microRNA and NETest are promising biomarkers with potential clinical benefit, but further researches are needed before their clinical applications.
Biomarkers, Tumor
;
blood
;
Chromogranin A
;
blood
;
Chromogranin B
;
blood
;
chemistry
;
Gastrointestinal Neoplasms
;
blood
;
chemistry
;
diagnosis
;
genetics
;
Humans
;
MicroRNAs
;
blood
;
Neoplastic Cells, Circulating
;
Neuroendocrine Tumors
;
blood
;
chemistry
;
diagnosis
;
genetics
;
Pancreatic Neoplasms
;
blood
;
chemistry
;
diagnosis
;
genetics
;
Pancreatic Polypeptide
;
blood
;
Phosphopyruvate Hydratase
;
blood
3.Improvement of prognostic and predictive network of colorectal cancer based upon the 8th edition of AJCC colorectal cancer staging system.
Hongwei YAO ; Hongwei WU ; Yinhua LIU
Chinese Journal of Gastrointestinal Surgery 2017;20(1):24-27
The 8th edition of AJCC cancer staging system will be launched all over the world in January 1, 2018. The major advances in the 8th edition are the introduction of non-anatomic prognostic and predictive factors supported by I(-II( grade evidence based on histopathology and molecular biology, and the improvement of prognostic assessment system based on these factors, including CEA level, cancer retraction score, circumference margin, lymphatic invasion, peripheral nerve invasion, microsatellite instability, KRAS/NRAS gene mutation and BRAF gene mutation. In the background of evidence-based medicine and precise medicine, combination of anatomic staging and non-anatomic classification system is very important for establishing and improving the prognostic and predictive assessment system of colorectal cancer. This will help to assess colorectal cancer staging and grouping much better, evaluate the prognosis, predict individualized efficacy, and promote clinical practice of colorectal cancer from traditional population-based diagnosis and treatment to the precise individualized care.
Carcinoembryonic Antigen
;
blood
;
Colorectal Neoplasms
;
classification
;
diagnosis
;
Female
;
Humans
;
Male
;
Microsatellite Instability
;
Mutation
;
Neoplasm Invasiveness
;
Neoplasm Staging
;
standards
;
Precision Medicine
;
methods
;
trends
;
Prognosis
;
Proto-Oncogene Proteins B-raf
;
genetics
;
Proto-Oncogene Proteins p21(ras)
;
genetics
4.Circular RNA in human disease and their potential clinic significance.
Yonghua CHEN ; Cheng LI ; Chunlu TAN ; Gang MAI ; Xubao LIU
Chinese Journal of Medical Genetics 2017;34(1):133-137
Circular RNAs (circ RNAs) are a novel type of RNA that, unlike linear RNAs, form a covalently closed continuous loop and are highly represented in the eukaryotic transcriptome. They share a stable structure, high expression and often exhibit tissue/developmental-stage-specific expression. Emerging evidence indicates that circRNAs might play important roles in human disease, such as cancer, neurological disorders and atherosclerotic vascular disease risk. The huge potentials of circRNAs are recently being discovered from the laboratory to the clinic. CircRNAs might be developed as a potential novel and stable biomarker and potential drugs used in disease diagnosis and treatment. Here, we review the current understanding of the roles of circRNAs in human disease and their potential clinic significance in disease.
Biomarkers
;
analysis
;
Disease
;
genetics
;
Gene Expression Regulation
;
Humans
;
Neoplasms
;
diagnosis
;
genetics
;
therapy
;
RNA
;
genetics
;
RNA Stability
;
Signal Transduction
;
genetics
5.Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities.
James R BAILEY ; Ashish AGGARWAL ; Thomas F IMPERIALE
Gut and Liver 2016;10(2):204-211
Colorectal cancer screening dates to the discovery of pre-cancerous adenomatous tissue. Screening modalities and guidelines directed at prevention and early detection have evolved and resulted in a significant decrease in the prevalence and mortality of colorectal cancer via direct visualization or using specific markers. Despite continued efforts and an overall reduction in deaths attributed to colorectal cancer over the last 25 years, colorectal cancer remains one of the most common causes of malignancy-associated deaths. In attempt to further reduce the prevalence of colorectal cancer and associated deaths, continued improvement in screening quality and adherence remains key. Noninvasive screening modalities are actively being explored. Identification of specific genetic alterations in the adenoma-cancer sequence allow for the study and development of noninvasive screening modalities beyond guaiac-based fecal occult blood testing which target specific alterations or a panel of alterations. The stool DNA test is the first noninvasive screening tool that targets both human hemoglobin and specific genetic alterations. In this review we discuss stool DNA and other commercially available noninvasive colorectal cancer screening modalities in addition to other targets which previously have been or are currently under study.
Biomarkers, Tumor/genetics
;
Colorectal Neoplasms/*diagnosis/genetics
;
DNA/analysis
;
Early Detection of Cancer/*methods
;
*Feces
;
Humans
;
Mass Screening/*methods
6.Orai1 Expression Is Closely Related with Favorable Prognostic Factors in Clear Cell Renal Cell Carcinoma.
Sayamaa LKHAGVADORJ ; Ji Hee KIM ; Sung Soo OH ; Mi Ra LEE ; Jae Hung JUNG ; Hyun Chul CHUNG ; Seung Kuy CHA ; Minseob EOM
Journal of Korean Medical Science 2016;31(6):879-885
Store-operated calcium (Ca2+) entry (SOCE) is the principal Ca2+ entry route in non-excitable cells, including cancer cells. We previously demonstrated that Orai1 and STIM1, the molecular components of SOCE, are involved in tumorigenesis of clear cell renal cell carcinoma (CCRCC). However, a clinical relevance of Orai1 and STIM1 expression in CCRCC has been ill-defined. Here, we investigated the expression of Orai1 and STIM1 in CCRCC, and compared their expression with clinico-pathological parameters of CCRCC and the patients' outcome. Immunohistochemical staining for Orai1 and STIM1 was performed on 126 formalin fixed paraffin embedded tissue of CCRCC and western blot analysis for Orai1 was performed on the available fresh tissue. The results were compared with generally well-established clinicopathologic prognostic factors in CCRCC and patient survival. Membrane protein Orai1 is expressed in the nuclei in CCRCC, whereas STIM1 shows the cytosolic expression pattern in immunohistochemical staining. Orai1 expression level is inversely correlated with CCRCC tumor grade, whereas STIM1 expression level is not associated with tumor grade. The higher Orai1 expression is significantly associated with lower Fuhrman nuclear grade, pathologic T stage, and TNM stage and with favorable prognosis. The expression level of STIM1 is not correlated with CCRCC grade and clinical outcomes. Orai1 expression in CCRCC is associated with tumor progression and with favorable prognostic factors. These results suggest that Orai1 is an attractive prognostic marker and therapeutic target for CCRCC.
Adolescent
;
Adult
;
Aged
;
Blotting, Western
;
Carcinoma, Renal Cell/*diagnosis/metabolism/*pathology
;
Female
;
*Gene Expression Regulation, Neoplastic
;
Humans
;
Immunohistochemistry
;
Kidney Neoplasms/metabolism/*pathology
;
Male
;
Middle Aged
;
Neoplasm Proteins/genetics/metabolism
;
ORAI1 Protein/genetics/*metabolism
;
Prognosis
;
Retrospective Studies
;
Stromal Interaction Molecule 1/genetics/metabolism
;
Young Adult
7.Acute Myeloid Leukemia With MLL Rearrangement and CD4+/CD56+ Expression can be Misdiagnosed as Blastic Plasmacytoid Dendritic Cell Neoplasm: Two Case Reports.
Ju Mee LEE ; In Suk KIM ; Jeong Nyeo LEE ; Sang Hyuk PARK ; Hyung Hoi KIM ; Chulhun L CHANG ; Eun Yup LEE ; Hye Ran KIM ; Seung Hwan OH ; Sae Am SONG
Annals of Laboratory Medicine 2016;36(5):494-497
No abstract available.
Adult
;
Antigens, CD4/*metabolism
;
Antigens, CD56/*metabolism
;
Bone Marrow/metabolism/pathology
;
Dendritic Cells/cytology/*metabolism
;
Diagnostic Errors
;
Exons
;
Female
;
Flow Cytometry
;
Gene Rearrangement
;
Hematologic Neoplasms/diagnosis
;
Histone-Lysine N-Methyltransferase/genetics
;
Humans
;
Immunohistochemistry
;
In Situ Hybridization, Fluorescence
;
Leukemia, Myeloid, Acute/*diagnosis
;
Male
;
Middle Aged
;
Myeloid-Lymphoid Leukemia Protein/genetics
;
Real-Time Polymerase Chain Reaction
;
Sequence Analysis, DNA
;
Transcription Factors/genetics
;
Translocation, Genetic
8.Immunohistochemical Analysis of ATRX, IDH1 and p53 in Glioblastoma and Their Correlations with Patient Survival.
Ajay CHAURASIA ; Sung Hye PARK ; Jeong Wook SEO ; Chul Kee PARK
Journal of Korean Medical Science 2016;31(8):1208-1214
Glioblastoma (GBM) can be classified into molecular subgroups, on the basis of biomarker expression. Here, we classified our cohort of 163 adult GBMs into molecular subgroups according to the expression of proteins encoded by genes of alpha thalassemia/mental retardation syndrome X-linked (ATRX), isocitrate dehydrogenase (IDH) and TP53. We focused on the survival rate of molecular subgroups, depending on each and various combination of these biomarkers. ATRX, IDH1 and p53 protein expression were evaluated immunohistochemically and Kaplan-Meier analysis were carried out in each group. A total of 15.3% of enrolled GBMs demonstrated loss of ATRX expression (ATRX-), 10.4% expressed an aberrant IDH1 R132H protein (IDH1+), and 48.4% exhibited p53 overexpression (p53+). Survival differences were statistically significant when single protein expression or different combinations of expression of these proteins were analyzed. In conclusion, in the case of single protein expression, the patients with each IDH1+, or ATRX-, or p53- GBMs showed better survival than patients with counterparts protein expressed GBMs. In the case of double protein pairs, the patients with ATRX-/p53-, ATRX-/IDH1+, and IDH1+/p53- GBMs revealed better survival than the patients with GBMs with the remained pairs. In the case of triple protein combinations, the patients with ATRX-/p53-/IDH+ showed statistically significant survival gain than the patients with remained combination of proteins-expression status. Therefore, these three biomarkers, individually and as a combination, can stratify GBMs into prognostically relevant subgroups and have strong prognostic values in adult GBMs.
Adult
;
Aged
;
Biomarkers, Tumor/metabolism
;
Brain Neoplasms/*diagnosis/metabolism/mortality
;
DNA Helicases/*metabolism
;
Disease-Free Survival
;
Glioblastoma/*diagnosis/metabolism/mortality
;
Humans
;
Immunohistochemistry
;
Isocitrate Dehydrogenase/*metabolism
;
Kaplan-Meier Estimate
;
Middle Aged
;
Nuclear Proteins/*metabolism
;
Retrospective Studies
;
Tumor Suppressor Protein p53/genetics/*metabolism
;
Young Adult
9.Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer.
Slawomir LAWICKI ; Edyta Katarzyna GLAZEWSKA ; Monika SOBOLEWSKA ; Grazyna Ewa BEDKOWSKA ; Maciej SZMITKOWSKI
Annals of Laboratory Medicine 2016;36(3):223-229
BACKGROUND: Macrophage colony-stimulating factor (M-CSF), matrix metalloproteinase-9 (MMP-9), and its specific tissue inhibitor - tissue inhibitor of metalloproteinases-1 (TIMP-1) may play an important role in the pathogenesis and spread of cancer. We investigated the plasma levels of M-CSF, MMP-9, and TIMP-1 in comparison with a commonly accepted tumor marker CA 15-3 in breast cancer patients and in control groups. METHODS: The cohort included 110 breast cancer patients in groups at stages I-IV. The control group consisted of 50 healthy volunteers and 50 benign tumor patients. Plasma levels of M-CSF, MMP-9, and TIMP-1 were determined by using ELISA, while CA 15-3 concentrations were determined by using chemiluminescent microparticle immunoassay (CMIA). RESULTS: The results showed significant differences in concentrations of the analyzed parameters and in levels of CA 15-3 between the groups of breast cancer patients and the two control groups. Diagnosis using these markers was equal to that using CA 15-3 in terms of sensitivity, predictive values of positive and negativetest results (PPV, NPV) and area under the ROC curve (AUC) in the studied groups. The diagnostic specificities of MMP-9, TIMP-1, M-CSF, and CA 15-3 showed equally high values (95%). The combined use of all tested parameters with CA 15-3 resulted in increased sensitivity, NPV, and AUC, especially in the combination of M-CSF with tumor markers (76%, 64%, and 0.8653). CONCLUSIONS: These findings suggest the tested parameters are useful in the diagnosis of breast cancer patients (except stage I), when combined with CA 15-3.
Adult
;
Aged
;
Area Under Curve
;
Biomarkers, Tumor/*blood
;
Breast Neoplasms/*diagnosis/genetics/pathology
;
Case-Control Studies
;
Female
;
Humans
;
Macrophage Colony-Stimulating Factor/*blood
;
Matrix Metalloproteinase 9/*blood
;
Middle Aged
;
Mucin-1/blood
;
Neoplasm Staging
;
Poland
;
ROC Curve
;
Sensitivity and Specificity
;
Tissue Inhibitor of Metalloproteinase-1/*blood
10.Clinical significance of human papillomavirus genotyping.
Journal of Gynecologic Oncology 2016;27(2):e21-
Cervical cancer is the fourth most common cancer in women worldwide, and the human papillomavirus (HPV) is the main causative agent for its development. HPV is a heterogeneous virus, and a persistent infection with a high-risk HPV contributes to the development of cancer. In recent decades, great advances have been made in understanding the molecular biology of HPV, and HPV\'s significance in cervical cancer prevention and management has received increased attention. In this review, we discuss the role of HPV genotyping in cervical cancer by addressing: clinically important issues in HPV virology; the current application of HPV genotyping in clinical medicine; and potential future uses for HPV genotyping.
DNA, Viral/*analysis
;
Early Detection of Cancer/*methods
;
Female
;
*Genome, Viral
;
Genotype
;
Humans
;
Papillomaviridae/classification/*genetics
;
Papillomavirus Infections/complications/drug therapy/*virology
;
Papillomavirus Vaccines/therapeutic use
;
Uterine Cervical Neoplasms/diagnosis/drug therapy/*virology

Result Analysis
Print
Save
E-mail